Annual Congress Stockholm 2002

Saturday, 14.09.2002
Sunday, 15.09.2002
Monday, 16.09.2002
Tuesday, 17.09.2002
Wednesday, 18.09.2002

Citations should be made in the following way: Authors. Title. Eur Respir J 2002; 20: Suppl. 38, abstract number.

Material from 2002:

3388 Abstracts
6 Slide presentations
5 Handouts

Material from 2002: Show

Airway reactivity

Thematic Poster Session
Chairs: P. J. Sterk (Leiden, The Netherlands), B. Ceyhan (Istanbul, Turkey)

Download all media

Formoterol provides rapid relief from acute dyspnoea following methacholine-induced bronchospasm H. J. van der Woude, M. Politiek, R. Aalbers (Groningen, The Netherlands)
Dose-response of inhaled corticosteroids on bronchial hyperresponsiveness: a meta-analysis G. P. Currie, S. J. Fowler, B. J. Lipworth (Dundee, United Kingdom)
Protective effect of inhaled beclomethasone dipropionate (BDP) in asthmatic patients with exercise-induced bronchoconstriction (EIB) M. D. Filipovic, S. S. Cekic, O. B. Dimitrijevic (Nis, Yugoslavia)
Comparison of salbutamul, nedocromil sodium and disodium cromoglycate (DSCG) protective effects in patients with exercise induced bronchoconstriction (EIB) S. S. Cekic, M. D. Filipovic, O. B. Dimitrijevic (Nis, Yugoslavia)
Differences in bronchoprotective subsensitivity between formoterol (FM) and salmeterol (SM) are associated with β₂-adrenoceptor polymorphism D. K. C. Lee, G. P. Currie, I. P. Hall, J. J. Lima, B. J. Lipworth (Dundee, Nottingham, United Kingdom; Jacksonville, United States Of America)
PD20 to methacholine is predicted by airway inflammation and remodelling; a systematic, longitudinal, steroid intervention study of airway biopsy (ebb) and BAL parameters C. Ward, D. Reid, M. Pais, B. Orsida, B. Feltis, R. Bish, D. Johns, E. H. Walters (Newcastle upon Tyne, United Kingdom; Hobart, Melbourne, Australia)
The presence of the arginine-16 β₂-adrenoceptor polymorphism (β₂-ARP) predisposes to bronchoprotective subsensitivity with long-acting β₂-agonists D. D. K. C. Lee, G. P. Currie, I. P. Hall, A. Wheatley, J. J. Lima, B. J. Lipworth (Dundee, Nottingham, United Kingdom; Jacksonville, United States Of America)
Do breathing exercises (buteyko and pranayama) help to control asthma: a randomised controlled trial S. Cooper, J. Oborne, S. Newton, V. Harrison, J. Thompson Coon, S. Lewis, A. E. Tattersfield (Harlow, Nottingham, United Kingdom)
Effects of 5-lipoxygenase inhibitor on airway responses to inhaled organic dust in healthy subjects B. M. Larsson, B. M. Sundblad, K. Larsson, S. E. Dahlén, M. Kumlin, L. Palmberg (Stockholm, Sweden)
Protection by formoterol and salmeterol on bronchoconstriction provoked by methacholine and AMP in asthmatics K. Richter, R. A. Joerres, S. Janicki, C. Louw, Y. Gnosspelius, H. Magnussen (Grosshansdorf, Germany; Lund, Sweden)
Sustained protection against activity-induced bronchospasm (AIB) during chronic treatment with the fluticasone propionate/salmeterol combination (FSC) P. Dorinsky, C. Kalberg, A. Emmett, K. Rickard (Research Triangle Park, United States Of America)
Effect of inhaled salmeterol or fluticasone on organic dust induced bronchial hyperreactivity A. Ek, B. M. Sundblad, L. Palmberg, K. Larsson (Stockholm, Sweden)
Timecourse of action of two inhaled corticosteroids, fluticasone propionate and budesonide K. Phillips, J. Oborne, S. Lewis, T. Harrison, A. Tattersfield (Camberley, Nottingham, United Kingdom)
The acute protective effect of a single dose of fluticasone propionate (FP) on the allergen-induced early asthmatic response in man R. I. Ketchell, M. B. Togher, G. W. Clarke, M. I. Allenby, B. J. O'Connor (London, United Kingdom)
Montelukast inhibits bronchoconstriction and gas exchange defects induced by leukotriene D₄ challenge in asthma A. Casas, F. P. Gómez, F. Burgos, B. Dahlén, S. E. Dahlén, J. A. Barberà, J. Roca, R. Rodriguez-Roisin (Barcelona, Spain; Stockholm, Sweden)